Guardant Health, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Guardant Health, Inc. reported Cash And Cash Equivalents At Carrying Value of $378.20 million for the year ending 2025.

  • Guardant Health, Inc. showed a decrease of -28.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Guardant Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), Guardant Health, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 423.2%.
  • Historical annual values: Fiscal year 2025: $378.20 million | Fiscal year 2024: $525.54 million | Fiscal year 2023: $1.13 billion | Fiscal year 2022: $141.65 million | Fiscal year 2021: $492.20 million | Fiscal year 2020: $832.98 million | Fiscal year 2019: $143.23 million | Fiscal year 2018: $140.54 million | Fiscal year 2017: $72.28 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: